Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis
Following infection with Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), most human hosts are able to contain the infection and avoid progression to active TB disease through expression of a balanced, homeostatic immune response. Proinflammatory mechanisms aiming to kill, slow...
Main Authors: | Stefanie Krug, Sadiya Parveen, William R. Bishai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.660916/full |
Similar Items
-
Harnessing DNA Repair Defects to Augment Immune-Based Therapies in Triple-Negative Breast Cancer
by: Curtis A. Clark, et al.
Published: (2021-09-01) -
Determination of low tetanus or diphtheria antitoxin titers in sera by a toxin neutralization assay and a modified toxin-binding inhibition test
by: M.H. Sonobe, et al.
Published: (2007-01-01) -
Diphtheritic myocarditis: A case series and review of literature
by: Sonali Singh, et al.
Published: (2020-01-01) -
Harnessing DNA Double-Strand Break Repair for Cancer Treatment
by: Anika Trenner, et al.
Published: (2019-12-01) -
PARP inhibitors in cancer therapy: Magic bullets but moving targets
by: Girish M. Shah, et al.
Published: (2013-11-01)